Completed
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
NCT00570635
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
- Locations
-
- Los Angeles, California, United States
- Park Ridge, Illinois, United States
- Boston, Massachusetts, United States